Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which surgery after miscarriage boosts future pregnancy?

NCT ID NCT02201732

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares hysteroscopy (using a tiny camera) to standard curettage (scraping) for removing leftover tissue after an incomplete miscarriage. It involved 577 women under 45 who wanted to get pregnant again. The main goal was to see which procedure leads to more successful pregnancies beyond 22 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hysteroscopy (a procedure using a small camera to remove tissue from the uterus)
What this could lead to
If hysteroscopy works better, it could improve future pregnancy chances after a miscarriage.
What could go wrong
This is a completed study, but results may not apply to all women. Both procedures carry risks like infection or injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

577 people

The number who actually took part.

Started

Nov 2014

Finished

Jul 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 44 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Major, under 45 years with intrauterine trophoblastic retention after incomplete miscarriage in the first quarter (termination of pregnancy \< 14 WA), * With desire of pregnancy ; * Intrauterine trophoblastic retention diagnosed by transvaginal pelvic ultrasound finding a intrauterine heterogeneous image or intrauterine gestational sac more than 15 mm in thickness, complicated or not of endometritis ; * Decision to surgical management of incomplete miscarriage by the health care team ; * Patient beneficiary or affiliated to a health insurance * Informed and signed consent Exclusion Criteria: Will not be included in the protocol patients : * having a uterine malformation known ; * having received surgical treatment for the current intrauterine retention ; * with intrauterine retention diagnosed by transvaginal pelvic ultrasound of more than 50 mm in thickness ; * requiring a haemostatic act in urgency for heavy vaginal bleeding (miscarriage haemorrhage) ; * bearer of intrauterine device ; * having an evolutive pregnancy; * having an ectopic pregnancy; * having a trophoblastic retention following a voluntary abortion ; * having a pregnancy achieved by medically assisted procreation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Incomplete miscarriage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abortion, Incomplete

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre hospitalier intercommunal de poissy-saint germain en Laye

    Poissy, 78300, France